01 1DARMERICA, LLC
02 1Qingdao Biopeptek Co., Ltd.
01 2Thymosin Alpha-1 Acetate
01 2U.S.A
NDC Package Code : 73212-015
Start Marketing Date : 2020-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-627
Start Marketing Date : 2019-09-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Thymalfasin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Thymalfasin, including repackagers and relabelers. The FDA regulates Thymalfasin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Thymalfasin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Thymalfasin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Thymalfasin supplier is an individual or a company that provides Thymalfasin active pharmaceutical ingredient (API) or Thymalfasin finished formulations upon request. The Thymalfasin suppliers may include Thymalfasin API manufacturers, exporters, distributors and traders.
click here to find a list of Thymalfasin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Thymalfasin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Thymalfasin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Thymalfasin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Thymalfasin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Thymalfasin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Thymalfasin suppliers with NDC on PharmaCompass.
We have 2 companies offering Thymalfasin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
